Pharmacotherapy for Cocaine Dependence

Treating Alcohol and Drug Abuse: An Evidence Based Review

Volumn , Issue , 2004, Pages 533-571

  Johansson, Björn Axel ^a  

^a NONE   (Sweden)

Author keywords

Antidepressants; Antiepileptics; Cocaine dependence; Disulfiram; Dopamine agonists; Methamphetamine dependence; Neuroleptics; Opioid agonist; Pharmacotherapy; Serotonin agonist; SSRI; Stimulants; blockers

Indexed keywords

EID: 20044363760     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527601465.ch9     Document Type: Chapter

References (42)

1. Alterman AI, Droba M, Antelo RE, Cornish JW, Sweeney KK, Parikh GA, O'Brien CP. Amantadine may facilitate detoxification of cocaine addicts. Drug Alcohol Depend 1992; 31:19-29.
2. Arndt IO, Dorozynsky L, Woody GE, McMellan AT, O'Brien CP. Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry 1992; 49:888-893.
3. Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O'Brien CP. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 1994; 182:151-156.
4. Batki SL, Washburn AM, Delucchi K, Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 1996; 41:137-142.
5. Campbell JL, Thomas HM, Gabrielli W, Liskow BI, Powell BJ. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings. J Addict Dis 1994; 13:191-199.
6. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FH. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51:177-187.
7. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51:989-997.
8. Carroll KM, Nich C, Rounsaville BJ. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis 1995; 183:251-259.
9. Cornish JW, Maany I, Fudala PJ, Neal S, Poole SA, Volpicelli P, O'Brien CP. Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend 1995; 38:221-227.
10. Cornish JW, O'Brien CP. Developing medications to treat cocaine dependence: a new direction. Curr Op Psychiatry 1998; 11:249-251.
11. Covi L, Hess JM, Kreiter NA, Haertzen CA. Effects of combined fluoxetine and counselling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21:327-344.
12. Crosby RD, Pearson VL, Eller C, Winegarden T, Graves NL. Phenytoin in the treatment of cocaine abuse: a double-blind study. Clin Pharmacol Ther 1996; 59: 458-468.
13. Eiler K, Schaefer MR, Salstrom D, Lowery R. Double-blind comparison of bromocriptine and placebo in cocaine withdrawal. Am J Drug Alcohol Abuse 1995; 21:65-79.
14. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D. Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 1994; 13:201-216.
15. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D. A controlled trail of imipramine for the treatment of metham-phetamine dependence. J Subst Abuse Treat 1996; 13:493-497.
16. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46:117-121.
17. Giannini AJ, Loiselle RH, Graham BH, Folts DJ. Behavioral response to buspirone in cocaine and phencyclidine withdrawal. J Subst Abuse Treat 1993; 10:523-27.
18. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled doubleblind trials. J Clin Psychopharmacol 1995; 15:163-174.
19. Halikas JA, Corsby RD, Koop LP, Crea F, Nugent SM, Carlson GA. Daily monitored cardiovascular effects of carbamazepine in chronic crack cocaine users. Psychopharmacol Bull 1991; 27:345-351.
20. Halikas JA, Corsby RD, Pearson VL, Graves NL. A randomized doubleblind study of carbamazepine in the treatment of cocaine abuse. Clin Pharmacol Ther 1997; 62:89-105.
21. Hall SM, Tunis S, Triffleman E, Banys P, Clark HW, Tusel D, Stewart P, Presti D. Continuity of care and desipramine in primary cocaine abusers. J Nerv Ment Dis 1994; 182:570-575.
22. Handelsman L, Limpitlaw L, Williams D, Schmeidler J, Paris P, Stimmel B. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. Drug Alcohol Depend 1995; 39:173-180.
23. Handelsman L, Rosenblum A, Palij M, Magura S, Foote J, Lovejoy M, Stimmel B. Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 1997; 6:54-64.
24. Kampman K, Volpicelli JR, Alterman A, Cornish J, Weinrib R, Epperson L, Sparkman T, O'Brien CP. Amantadine in the early treatment of cocaine dependence: a double-blind, placebocontrolled trial. Drug Alcohol Depend 1996; 41:25-33.
25. Kolar AF, Brown BS, Weddington WW, Heartzen CC, Michaelson BS, Jaffe JH. Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. Int J Addict 1992; 27:849-868.
26. Kosten TR, Morgan CH, Schottenfeld RS. Amantadine and desipramine in the treatment of cocaine-abusing methadone maintained patients. NIDA Res Monogr 1991; 105:510-511.
27. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992; 49:894-898.
28. Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Carbamazepine treatment of cocaine dependence: a placebo- controlled trial. Drug Alcohol Depend 1995; 38:203-211.
29. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994; 35:31-35.
30. Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, Ascher JA, Li SH. A multicenter trial of bupropion for cocaine dependence in methadonemaintained patients. Drug Alcohol Depend 1995; 40:125-131.
31. Margolin A, Avants SK, Kosten TR. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. Am J Drug Alcohol Abuse 1995; 21:469-481.
32. Montoya ID, Levin FR, Fudala PJ, Gorelick DA. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend 1995; 38:213-219.
33. Moscovitz H, Brookoff D, Nelson, L. A randomized trial of bromocriptine for cocaine users presenting to the emergency department. J Gen Intern Med 1993; 8:1-4.
34. Nunes EV, McGrath PJ, Quitkin FM, Ocepek-Welikson K, Stewart JW, Koenig T, Wager S, Klein DF. Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend 1995; 39:185-195.
35. O'Brien CP. Recent developments in the pharmacotherapy of substance abuse. J Consult Clin Psychol 1996; 64:677-686.
36. Preston KL, Sullivan JT, Berger P, Bigelow GE. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J Pharmacol Exp Ther 1993; 267:296-307.
37. Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR. Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study. Am J Drug Alcohol Abuse 1993; 19:451-464.
38. Stine SM, Krystal JH, Kosten TR, Charney DS. Mazindol treatment for cocaine dependence. Drug Alcohol Depend 1995; 39:245-252.
39. Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 1994; 14:396-407.
40. Weddington WW Jr, Brown BS, Haertzen CA, Hess JM, Mahaffey JR, Kolar AF, Jaffe JH. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17:137-152.
41. Ziedonis DM, Kosten TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs 1991; 23:417-425.
42. Ziedonis DM, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27:337-343.